The lncRNA 44s2 Study Applicability to the Design of 45-55 Exon Skipping Therapeutic Strategy for DMD.

Biomedicines · 2021 · PMC7924625 · PMID 33672764

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Low lncRNA Expression during Differentiation in Human Myoblasts The lncRNA expression was investigated 3 days after differentiation in immortalized myoblasts and showed a trend to increased expression in Hthy-I compared to 45-52-I cells, but we could not demonstrate a significant difference ( p = 0.3) between the various conditions due to the elevated variability in cells (Figure, 4D right).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.